关注
Marion Bareille
Marion Bareille
未知所在单位机构
在 uclouvain.be 的电子邮件经过验证
标题
引用次数
引用次数
年份
Viscoelastometric testing to assess hemostasis of COVID-19: a systematic review
M Bareille, M Hardy, J Douxfils, S Roullet, D Lasne, JH Levy, A Stépanian, ...
Journal of clinical medicine 10 (8), 1740, 2021
592021
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: a prospective longitudinal observational study
M Hardy, I Michaux, S Lessire, J Douxfils, JM Dogné, M Bareille, G Horlait, ...
Thrombosis research 197, 20, 2021
472021
Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data
M Hardy, I Michaux, S Lessire, J Douxfils, JM Dogné, M Bareille, G Horlait, ...
Data in brief 33, 106519, 2020
242020
Studies on hemostasis in COVID‐19 deserve careful reporting of the laboratory methods, their significance, and their limitations
M Hardy, J Douxfils, M Bareille, S Lessire, I Gouin‐Thibault, P Fontana, ...
Journal of Thrombosis and Haemostasis 18 (11), 3121-3124, 2020
202020
Are viscoelastometric assays of old generation ready for disposal? Comment on Volod et al. Viscoelastic hemostatic assays: A primer on legacy and new generation devices. J …
M Bareille, T Lecompte, F Mullier, S Roullet
Journal of clinical medicine 12 (2), 477, 2023
92023
Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’
M Hardy, M Bareille, T Lecompte, F Mullier
Thrombosis research 214, 63-64, 2022
62022
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system
M Bareille, M Hardy, B Chatelain, T Lecompte, F Mullier
Thrombosis journal 20 (1), 73, 2022
22022
Letter in response to Othman & Favaloro “Comparison of two ways of performing ristocetin-induced platelet agglutination (RIPA) mixing study for diagnosis of type 2B VWD”
R Soleimani, M Khourssaji, J Cabo, M Guldenpfennig, J Baudar, ...
Research and practice in thrombosis and haemostasis 7 (6), 2023
12023
PB1211 Individual Determination of the Components of the Fibrinolytic System in Platelet-Depleted Plasma and Derived Euglobulin Fraction
M Bareille, T Lecompte, F Mullier
Research and Practice in Thrombosis and Haemostasis 7, 2023
2023
Assessment of the individual determinants of two fibrinolysis assays, GFC and ECLT in platelet-depleted plasma and derived euglobulin fraction respectively
M Bareille, T Lecompte, F Mullier
Thrombosis research 230, 33-36, 2023
2023
INDIVIDUAL DETERMINATION OF THE COMPONENTS OF THE FIBRINOLYTIC SYSTEM IN PLATELET-DEPLETED PLASMA AND DERIVED EUGLOBULIN FRACTION
M Bareille, T Lecompte, F Mullier
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY 45, 10-10, 2023
2023
INFLUENCE OF CENTRIFUGATION AND RESIDUAL PLATELET COUNT ON PAI-1 PLASMA LEVEL, EUGLOBULIN CLOT LYSIS TIME AND GLOBAL FIBRINOLYTIC CAPACITY OF PLASMA
M Bareille, T Lecompte, F Mullier
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY 45, 14-14, 2023
2023
Towards optimized red blood cells ordering prior to cardiac surgery: a single center retrospective study
AS Dincq, L Thiltgès, I Michaux, M Gourdin, G Kalscheuer, L Melly, ...
Acta Anaesthesiologica Belgica 73, 207, 2022
2022
researchportal. unamur. be
M Hardy, I Michaux, S Lessire, J Douxfils, JM Dogné, M Bareille, G Horlait, ...
International Journal of Pharmaceutics 593, 120107, 2021
2021
Evaluatie van het tromboserisico en therapeutisch beleid bij covid-19-patiënten die in het ziekenhuis worden opgenomen
M Pouplard, M Hardy, M Bareille, AL Sennesael, A Spinewine, AS Larock, ...
Onco Hemato 14, 38, 2020
2020
Évaluation et prise en charge du risque thrombotique chez les patients hospitalisés atteints de Covid-19
M Pouplard, M Hardy, M Bareille, AL Sennesael, A Spinewine, AS Larock, ...
Onco Hemato 14, 38, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–16